Quanta Dialysis Technologies Partners with Innovative Renal Care to Enhance Dialysis Access Across the USA

Quanta Dialysis Technologies and Innovative Renal Care Form Strategic Partnership

In a significant move for kidney care in the United States, Quanta Dialysis Technologies has formed a multi-year strategic alliance with Innovative Renal Care (IRC), aimed at expanding the reach of the innovative Quanta™ Dialysis System to patients across various healthcare settings. This collaboration comes as a response to the pressing need for advanced dialysis solutions, enabling better patient access to high-quality kidney care.

About the Partnership

Announced on September 3, 2025, the partnership focuses on broadening access to Quanta's state-of-the-art dialysis technology within select IRC programs. The agreement emphasizes not only the availability of the Quanta Dialysis System in hospitals but also its application in acute care settings, which has shown tremendous potential in improving patient outcomes.

Pilot Program Success

Earlier in the year, IRC initiated a pilot program at MercyOne Waterloo Medical Center in Iowa. This program served to evaluate the Quanta Dialysis System's versatility and usability across various care environments, including intensive care units and dialysis suites. Since its launch, over 130 treatments, including gentle Continuous Renal Replacement Therapy (CRRT) for hemodynamically unstable patients, have been successfully carried out with this technology.

The success of this pilot led to a formal purchase agreement between IRC and Quanta, covering not only equipment and disposables but also facilitating electronic medical record (EMR) integration for enhanced therapy monitoring and data insights.

Key Benefits of Quanta Dialysis System

Quanta Dialysis Technologies brings various unique benefits to the table, which are vital in the fast-evolving landscape of healthcare:

1. Prescription Flexibility: The Quanta Dialysis System can perform three types of dialysis – CRRT, Sustained Low Efficiency Dialysis (SLED), and Intermittent Hemodialysis (IHD) – all on a single device. This flexibility allows medical professionals to tailor treatments to patients' specific needs.
2. Portability and User-Friendliness: The system's compact design ensures that it is portable and easy to use for healthcare staff, making it feasible to set up in various settings, be it a hospital, bedside, or home.
3. Operational Excellence: The Quanta system promotes operational improvements through reduced maintenance and disinfection needs. This results in measurable cost savings for healthcare providers, allowing them to allocate resources more effectively.
4. Service Flexibility: IRC has the option to train its staff to conduct maintenance on the machines or to utilize Quanta’s full-service solutions for repairs, ensuring adaptability in service management.

These advantages provide IRC a significant competitive edge in managing the continuum of care for dialysis patients, streamlining operations, and minimizing delays associated with treatment. As more healthcare settings recognize these benefits, the Quanta Dialysis System is set to play a pivotal role in enhancing patient care.

Positive Impact on Patient Care

Sara Brady, Chief Nursing Officer of IRC, highlighted the excitement within care teams about the innovative dialysis options now available for acute care patients. With the Quanta Dialysis System, healthcare providers can make immediate treatment adjustments, which is expected to revolutionize patient experiences within acute care settings.

Alejandro Galindo, CEO of Quanta, echoed this sentiment by expressing enthusiasm for the collaboration. He noted that this opportunity confirms the growing recognition among leading dialysis providers of the clinical and economic benefits the Quanta system fosters.

Conclusion

As Quanta Dialysis Technologies and Innovative Renal Care continue to build momentum throughout this partnership, this agreement stands as a testament to the commitment to innovative kidney care solutions. Both organizations aim to lead the charge in transforming how dialysis treatment is administered across the United States, making significant strides towards improved patient care and outcomes.